Prognia
Drug Database
🇪🇺EU · EMAWithdrawnATC: B02BC30

Evarrest(human fibrinogen;human thrombin)

Hemostasis

Marketing Authorisation Holder: Omrix Biopharmaceuticals N. V.

EMA Authorisation: 25/09/2013

INN: human fibrinogen;human thrombin

Indication

Supportive treatment in adult surgery where standard surgical techniques are insufficient (see section 5.1): - for improvement of haemostasis.

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Evarrest — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.